Announcements
Expression of concern regarding paper by Park et al, published on 25 June 2015: “Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015”, Euro Surveill. 2015;20(25):pii=21169. It has been brought to our attention that some of the authors may not have been informed about the content of the above paper. There is a lack of clarity regarding rights to use the data. The editorial team are investigating what action needs to be taken.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance


In this issue


Home Eurosurveillance Edition  2016: Volume 21/ Issue 4 Article 7
Back to Table of Contents
Previous

Eurosurveillance, Volume 21, Issue 4, 28 January 2016
Addendum
Weidmann: Addendum for Euro Surveill. 2015;20(44)

+ Author affiliations


Citation style for this article: Weidmann M. Addendum for Euro Surveill. 2015;20(44). Euro Surveill. 2016;21(4):pii=30121. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2016.21.4.30121

Received:28 January 2016; Accepted:28 January 2016

For the article ‘Development and deployment of a rapid recombinase polymerase amplification Ebola virus detection assay in Guinea in 2015’ (http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=21289), by Faye et al., published on 05 November 2015, the authors would like to add that the World Health Organisation (WHO)-approved RealStar Filovirus Screen RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany) has been widely used on Smart Cyclers throughout the Ebola outbreak in West Africa, although the manufacturer does not list this device in their instructions for use. The company published a note on its website on 10 July 2015 (http://www.altona-diagnostics.com/news-detail/altona-diagnostics-gmbH-letter-to-the-editor.html), commenting the reported lack of sensitivity of this kit when used on a Smart Cycler. According to our findings, we consider that the reported lack of sensitivity is related to the restriction of using the kit for specific PCR cyclers only, as also found by other groups [1] previously.



References

  1. Janvier F, Sagui E, Foissaud V. ReEBOV Antigen Rapid Test kit for Ebola.Lancet. 2015;386(10010):2254-5. DOI: 10.1016/S0140-6736(15)01107-1 PMID: 26681288



Back to Table of Contents
Previous

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.